Practical Considerations for Recognizing and Managing Severe Irritable Bowel Syndrome
The DOI matches its Crossref record; 59 of the 61 references it cites were found in a registry or an index.
Abstract
Irritable bowel syndrome (IBS) is a common disorder characterized by abdominal pain or discomfort and altered bowel habit (chronic or recurrent diarrhea, constipation, or both) that occurs more frequently in women than in men. Severe IBS may be underrecognized and inadequately managed in clinical practice. Although no consensus definition for "severe IBS" exists, patients may be categorized as having severe illness if they show an insufficient response to conventional treatments or if their functionality or quality of life is impaired as a result of their IBS symptoms. Nurses can be an important resource in optimizing the evaluation and treatment of these patients. Nursing assessments that delineate predominant symptoms and the history and nature of prior interventions (e.g., lifestyle changes, over-the-counter or prescription medication trials, psychotherapy, alternative treatments) and subsequent responses are important when advising patients and participating in the management of their IBS. Likewise, the nurse's assessment should include a history of symptom severity and impact on daily functioning, as these elements are important to choosing therapy. The nurse-patient dialogue should also include a description of available treatment options and the benefits and risks associated with each. By maintaining such a dialogue, nurses can hasten IBS recognition, improve management, limit the negative consequences of this common disorder, and improve overall treatment outcomes in this population.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
O’Mahony, L., McCarthy, J., Kelly, P., Hurley, G., Luo, F., Chen, K., O’Sullivan, G. C., Kiely, B., Collins, J. K., Shanahan, F., et al. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.11.050 · Cited by 1,448
Components of placebo effect: randomised controlled trial in patients with irritable bowel syndrome
Kaptchuk, T. J., Kelley, J. M., Conboy, L. A., Davis, R. B., Kerr, C. E., Jacobson, E. E., Kirsch, I., Schyner, R. N., Nam, B. H., Nguyen, L. T., et al. (2008) · BMJ · doi:10.1136/bmj.39524.439618.25 · Cited by 1,196
Whitehead, W. E., Palsson, O., & Jones, K. R. (2002) · Gastroenterology · doi:10.1053/gast.2002.32392 · Cited by 1,116
Rifaximin Therapy for Patients with Irritable Bowel Syndrome without Constipation
Pimentel, M., Lembo, A., Chey, W. D., Zakko, S., Ringel, Y., Yu, J., Mareya, S. M., Shaw, A. L., Bortey, E., & Forbes, W. P. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1004409 · Cited by 1,036 · cited 1×
“Results from two large, identically designed, multicenter trials of rifaximin in nonconstipated IBS were recently reported (Pimentel et al., 2011).”
BackgroundWhorwell, P. J., Altringer, L., Morel, J., Bond, Y., Charbonneau, D., O'Mahony, L., Kiely, B., Shanahan, F., & Quigley, E. M. M. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00734.x · Cited by 799
The impact of irritable bowel syndrome on health-related quality of life
Gralnek, I. M., Hays, R. D., Kilbourne, A., Naliboff, B., & Mayer, E. A. (2000) · Gastroenterology · doi:10.1053/gast.2000.16484 · Cited by 781 · cited 1×
“Research has highlighted levels of impairments in health-related QoL and physical role limitations in IBS that are similar to, or greater than, those found in other chronic diseases, such as diabetes mellitus (Gralnek, Hays, Kilbourne, Naliboff, & Mayer, 2000) or major depressive disorder (Gralnek et al., 2000).”
BackgroundAn Evidence-Based Position Statement on the Management of Irritable Bowel Syndrome
American College of Gastroenterology IBS Task Force (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2008.122 · Cited by 694
Pimentel, M. (2003) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(02)05902-6 · Cited by 669
Our new president—Jon I. Isenberg, M.D
Boland, C. R., & Yamada, T. (2001) · Gastroenterology · doi:10.1053/gast.2001.24057 · Cited by 629
Ford, A. C., Talley, N. J., Schoenfeld, P. S., Quigley, E. M. M., & Moayyedi, P. (2009) · Gut · doi:10.1136/gut.2008.163162 · Cited by 582
Camilleri, M., Northcutt, A. R., Kong, S., Dukes, G. E., McSorley, D., & Mangel, A. W. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02033-x · Cited by 556
(2011) · SpringerReference · doi:10.1007/springerreference_44317 · Cited by 545
Irritable bowel syndrome in the United States: prevalence, symptom patterns and impact
Hungin, A. P. S., Chang, L., Locke, G. R., Dennis, E. H., & Barghout, V. (2005) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2005.02463.x · Cited by 494 · cited 1×
“The prevalence rates of the IBS subtypes are uncertain and contradictory, with separate studies suggesting that either IBS with diarrhea (IBS-D) or the alternating or mixed form of IBS (IBS-M) is most common (American Gastroenterological Association, 2002; Andrews et al., 2005; Hungin et al., 2005).”
BackgroundSmall Intestinal Bacterial Overgrowth: A Framework for Understanding Irritable Bowel Syndrome
Lin, H. C. (2004) · JAMA · doi:10.1001/jama.292.7.852 · Cited by 396 · cited 1×
“Interest in rifaximin for IBS arose from the hypothesis that small intestinal bowel overgrowth contributes to the IBS symptoms of gas, bloating, and altered bowel function through the fermentation of ingested lactulose by gut bacteria and the stimulation of a gut immune response (Lin, 2004).”
BackgroundThe Utility of Probiotics in the Treatment of Irritable Bowel Syndrome: A Systematic Review
Brenner, D. M., Moeller, M. J., Chey, W. D., & Schoenfeld, P. S. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2009.25 · Cited by 362
The Irritable Bowel Syndrome: Review and a Graduated Multicomponent Treatment Approach
Drossman, D. A., & Thompson, W. G. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-116-12-1009 · Cited by 309
Camilleri, M., Chey, W. Y., Mayer, E. A., Northcutt, A. R., Heath, A., Dukes, G. E., McSorley, D., & Mangel, A. M. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.14.1733 · Cited by 302
Role of serotonin in gastrointestinal motility and irritable bowel syndrome
Sikander, A., Rana, S. V., & Prasad, K. K. (2009) · Clinica Chimica Acta · doi:10.1016/j.cca.2009.01.028 · Cited by 279
Ginger extract inhibits LPS induced macrophage activation and function
Tripathi, S., Bruch, D., & Kittur, D. S. (2008) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-8-1 · Cited by 258
Drossman, D. A., Morris, C. B., Schneck, S., Hu, Y. J. B., Norton, N. J., Norton, W. F., Weinland, S. R., Dalton, C., Leserman, J., & Bangdiwala, S. I. (2009) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e318189a7f9 · Cited by 235
Clinical Determinants of Health-Related Quality of Life in Patients With Irritable Bowel Syndrome
Spiegel, B. M. R., Gralnek, I. M., Bolus, R., Chang, L., Dulai, G. S., Mayer, E. A., & Naliboff, B. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.16.1773 · Cited by 200
Lembo, T. (2001) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(01)02690-9 · Cited by 192
Prevalence and demographics of irritable bowel syndrome: results from a large web‐based survey
ANDREWS, E. B., EATON, S. C., HOLLIS, K. A., HOPKINS, J. S., AMEEN, V., HAMM, L. R., COOK, S. F., TENNIS, P., & MANGEL, A. W. (2005) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2005.02671.x · Cited by 188
Hahn, B. A., Kirchdoerfer, L. J., Fullerton, S., & Mayer, E. (1997) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.1997.00160.x · Cited by 178
Lackner, J. M., Jaccard, J., Krasner, S. S., Katz, L. A., Gudleski, G. D., & Holroyd, K. (2008) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2008.03.004 · Cited by 176
Chey, W. D., Chey, W. Y., Heath, A. T., Dukes, G. E., Carter, E. G., Northcutt, A., & Ameen, V. Z. (2004) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2004.30509.x · Cited by 150
Treatment of the Irritable Bowel Syndrome with Bentyl® (Dicyclomine Hydrochloride)
Page, J. G., & Dirnberger, G. M. (1981) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-198106000-00009 · Cited by 135
(2001) · PubMed · Cited by 132
Suicidal ideation in patients with irritable bowel syndrome
Miller, V., Hopkins, L., & Whorwell, P. J. (2004) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(04)00545-2 · Cited by 120
Krause, R., Ameen, V., Gordon, S. H., West, M., Heath, A. T., Perschy, T., & Carter, E. G. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01282.x · Cited by 119
Self-management for women with irritable bowel syndrome
Heitkemper, M. M., Jarrett, M. E., Levy, R. L., Cain, K. C., Burr, R. L., Feld, A., Barney, P., & Weisman, P. (2004) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(04)00242-3 · Cited by 119 · cited 1×
“Cognitive–behavioral therapy has been combined with education, relaxation training, and diet management in what is termed a comprehensive self-management approach to IBS, with the intervention administered by trained psychiatric nurse practitioners (Heitkemper et al., 2004; Jarrett et al., 2009).”
MethodSelf-citationAmerican Gastroenterological Association medical position statement: Irritable bowel syndrome
(2002) · Gastroenterology · doi:10.1053/gast.2002.37095b · Cited by 115
Irritable Bowel Syndrome: Toward an Understanding of Severity
Lembo, A. J., Ameen, V. Z., & Drossman, D. A. (2005) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(05)00157-6 · Cited by 111
Duloxetine in the treatment of irritable bowel syndrome: an open‐label pilot study
Brennan, B. P., Fogarty, K. V., Roberts, J. L., Reynolds, K. A., Pope, H. G., & Hudson, J. I. (2009) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.1038 · Cited by 99
Systematic review: the effectiveness of hypnotherapy in the management of irritable bowel syndrome
WILSON, S., MADDISON, T., ROBERTS, L., GREENFIELD, S., SINGH, S., & ON BEHALF OF THE BIRMINGHAM IBS RESEARCH GROUP (2006) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.03028.x · Cited by 91
Jarrett, M. E., Cain, K. C., Burr, R. L., Hertig, V. L., Rosen, S. N., & Heitkemper, M. M. (2009) · American Journal of Gastroenterology · doi:10.1038/ajg.2009.479 · Cited by 89
Self-citationAlosetron Improves Quality of Life in Women With Diarrhea-Predominant Irritable Bowel Syndrome
Watson, M. E., Lacey, L., Kong, S., Northcutt, A. R., McSorley, D., Hahn, B., & Mangel, A. W. (2001) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2001.03525.x · Cited by 88
The usual medical care for irritable bowel syndrome
Whitehead, W. E., Levy, R. L., Von Korff, M., Feld, A. D., Palsson, O. S., Turner, M., & Drossman, D. A. (2004) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2004.02256.x · Cited by 88
Serotonin and its implication for the management of irritable bowel syndrome.
Gershon (2003) · PubMed · Cited by 81
Treatments for irritable bowel syndrome: patients' attitudes and acceptability
Harris, L. R., & Roberts, L. (2008) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-8-65 · Cited by 73
Self-citationLembo, A. J., Olden, K. W., Ameen, V. Z., Gordon, S. L., Heath, A. T., & Carter, E. G. (2004) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(04)00284-8 · Cited by 72
Determinants of healthcare‐seeking behaviour among subjects with irritable bowel syndrome
WILLIAMS, R. E., BLACK, C. L., KIM, H. ‐., ANDREWS, E. B., MANGEL, A. W., BUDA, J. J., & COOK, S. F. (2006) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.02928.x · Cited by 69
Review: The treatment of irritable bowel syndrome
Lacy, B. E., Weiser, K., & De Lee, R. (2009) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x09104794 · Cited by 66
Rationale for using serotonergic agents to treat irritable bowel syndrome
Baker, D. E. (2005) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/62.7.700 · Cited by 63
Drossman, D. A. (2009) · American Journal of Gastroenterology · doi:10.1038/ajg.2009.341 · Cited by 63
Cognitive-Behavioral Treatment of Irritable Bowel Syndrome
Toner, B. B. (2005) · CNS Spectrums · doi:10.1017/s1092852900019854 · Cited by 53
The role of serotonin in the pathophysiology of irritable bowel syndrome.
Crowell (2001) · The American Journal of Managed Care · Cited by 53
The growing case for hypnosis as adjunctive therapy for functional gastrointestinal disorders
Palsson, O. S., & Whitehead, W. E. (2002) · Gastroenterology · doi:10.1053/gast.2002.37286 · Cited by 53
The role of serotonin in the pathophysiology of irritable bowel syndrome.
Crowell, M. D. (2001) · PubMed · Cited by 47
Cognitive behaviour therapy for irritable bowel syndrome
Hutton, J. (2005) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200501000-00003 · Cited by 45
Evolution of Clinical Trials for Irritable Bowel Syndrome: Issues in End Points and Study Design
Trentacosti, A. M., He, R., Burke, L. B., Griebel, D., & Kennedy, D. L. (2010) · American Journal of Gastroenterology · doi:10.1038/ajg.2010.12 · Cited by 42
Psychological approach to managing irritable bowel syndrome
Hayee, B., & Forgacs, I. (2007) · BMJ · doi:10.1136/bmj.39199.679236.ae · Cited by 40
Lewis, J. H. (2010) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/egh.09.72 · Cited by 29
Treatment for Bacterial Overgrowth in the Irritable Bowel Syndrome
Drossman, D. A. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-145-8-200610170-00012 · Cited by 23
Heitkemper, M. M., Olden, K. W., Gordon, S., Carter, E., & Chang, L. (2001) · Gastroenterology Nursing · doi:10.1097/00001610-200111000-00005 · Cited by 17
Self-citationChey, W. D., Drossman, D. A., Scott, C., Panas, R. M., & Ueno, R. (2008) · Gastroenterology · doi:10.1016/s0016-5085(08)60139-0 · Cited by 9
Irritable bowel syndrome and disease severity: are we undertreating our patients?
Lacy, B. E. (2010) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/egh.09.71 · Cited by 9
Drossman, D. A., Chey, W. D., Scott, C., Panas, R. M., & Ueno, R. (2008) · Gastroenterology · doi:10.1016/s0016-5085(08)62197-6 · Cited by 7
Treatment of Irritable Bowel Syndrome
Coon, K. A. (2005) · The Primary Care Companion For CNS Disorders · doi:10.4088/pcc.v07n0507 · Cited by 5
Research works printed but not linked: 1
- Spiegel, 2010, Patient-reported symptom relief from current therapy is a robust marker of illness severity in IBS abstract 865., Gastroenterology, 5, S119
Cited by
British Society of Gastroenterology guidelines on the management of irritable bowel syndrome
Vasant, D. H., Paine, P. A., Black, C. J., Houghton, L. A., Everitt, H. A., Corsetti, M., Agrawal, A., Aziz, I., Farmer, A. D., Eugenicos, M. P., et al. (2021) · Gut · doi:10.1136/gutjnl-2021-324598 · Cited by 592
Asal, M. G. R., El‐Sayed, A. A. I., Alsenany, S. A., Ramzy, Z. H., & Dawood, R. F. A. (2025) · BMC Nursing · doi:10.1186/s12912-024-02594-5 · Cited by 10
Moore, J. S., Gagan, M. J., & Perry, R. E. (2014) · Gastroenterology Nursing · doi:10.1097/sga.0000000000000073 · Cited by 10
Usher, L., Fox, P., Lafarge, C., & Mitchell, K. (2013) · Psychology Community & Health · doi:10.5964/pch.v2i3.65 · Cited by 12
Harris, L. A., & Umar, S. B. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1498-2_16 · Cited by 7
Self-citation
Metadata
- Authors
- Harris, L. A., & Heitkemper, M. M.
- Affiliations
- Mayo Clinic (US)
- Corresponding author
- Harris, Lucinda A.
- Venue
- Gastroenterology Nursing
- Published
- 2012-01
- Volume
- 35
- Issue
- 1
- Pages
- 12-21
- ISSN
- 1042-895X (ISSN-L)
- OpenAlex
- W2326136019
- Cited by
- 12
- References
- 61
- Citations by year
- 2025: 1 · 2021: 1 · 2018: 2 · 2014: 4 · 2013: 3 · 2012: 1
- FWCI
- 2.48
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Gastroenterology Nursing (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Prometheus
- U.S. Food and Drug Administration
- Topics
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Health Sciences › Medicine › Urology › Pelvic floor disorders treatments
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Infant Health and Development
- Keywords
- irritable bowel syndrome, nursing assessment, nurse-patient communication, symptom severity, quality of life, treatment response, chronic diarrhea, constipation, abdominal pain
- MeSH terms
- Female, Humans, Male, Nurse's Role, Irritable Bowel Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.